A Study of MabThera (Rituximab) in Primary Central Nervous System Lymphoma.
Clinical trial NCT00517699 · TERMINATED
Trial details
- NCT number
- NCT00517699
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2009-03-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.